Saturday, April 12, 2025
April 06 - 08, 2024; Atlanta, Georgia
ACC 2024
Spirituality Intervention Tied to Lower Blood Pressure
ACC 2024
Telemedicine Boosts GDMT Rates for HFrEF in Navajo Nation
ACC 2024
Complete Revasc Not Superior to Culprit-Only PCI After MI
ACC 2024
Adding ACEI to Chemotherapy Does Not Prevent Cardiotoxicity
ACC 2024
Novel PCSK9 Inhibitor Reduced LDL by 50%
ACC 2024
Alcohol-Mediated Renal Denervation Promising in Hypertension
ACC 2024
Exercise Plus Protein Boosts TAVR Outcomes in Frail Patients
ACC 2024
Earlier Inclisiran Gives Better Long-Term LDL Reductions
ACC 2024
Neutral Result With Novel Agent in Diabetic Cardiomyopathy
ACC 2024
TAVI Comparable With SAVR in Lower-Risk Aortic Stenosis
ACC 2024
IVUS Bests Angiography to Guide PCI in ACS
ACC 2024
Single-Dose Zilebesiran Cuts BP Out to 6 Months: KARDIA-2
ACC 2024
Novel Drug Shows a Signal to Improve nHCM
ACC 2024
Coronary Sinus Reducer an Option for Intractable Angina?
ACC 2024
New Data Question Beta-Blockers Post-MI With Preserved EF
ACC 2024
For Small Annuli, Self-Expanding TAVR May Have an Advantage
ACC 2024
Substantial Triglyceride Reduction With Plozasiran
ACC 2024
Preventive PCI for Vulnerable Plaques Reduces Cardiac Events
ACC 2024
Early Olezarsen Results Show 50% Reduction in Triglycerides
ACC 2024
Web-Based App Allows Nonprescription Statin Use
ACC 2024
Dollars, Points Help CV Patients Increase Activity
ACC 2024
Semaglutide Beneficial in HFpEF Patients With Diabetes
ACC 2024
Ticagrelor Alone Cuts Bleeding Without More Events Post-PCI
ACC 2024
Chelation Therapy Provides No Benefit Post-MI
ACC 2024
Telemedicine Reduces Readmission in Post-PCI ACS Patients
ACC 2024
Mandibular Device Comparable to CPAP to Reduce BP
ACC 2024
Impella CP Improves Survival in STEMI, Cardiogenic Shock
ACC 2024
Empagliflozin Fails to Reduce Events After Acute MI
ACC 2024
ApoA1 Trial Misses Endpoint, But HDL Hypothesis Still Alive?
ACC 2024
No Net HF Benefit for Interatrial Shunt Device
ACC 2024
SGLT2 Inhibitors Safe for HF in Congenital Heart Disease
ACC 2024
Lp(a) Tied to Higher CVD Events; Risk Reduction With IPE
© WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Food Is Not Medicine but Maybe It's Healthcare
Calcium and CV Risk: Are Supplements and Vitamin D to Blame?
Coronary Artery Disease: The New Big C
Patient-Reported Outcomes in Heart Failure: How Do You Feel?
Highlights in Atherosclerosis and Lipids From ACC 2024
Threshold for Transfusion in ACS: Still Room for Discretion
Chelation Therapy and CV Risk: Why TACT2 Showed No Benefit
A Shot in the Arm for Uncontrolled Hypertension
EMPACT-MI: Another SGLT2 Inhibitor Miss Post-MI
Semaglutide Benefits in HFpEF Take a Step Beyond Weight Loss
Preventive Coronary Stents: Not There Yet
Beta-Blockers Post-MI Past Their Expiration Date: REDUCE-AMI
Impella Saves Lives in Cardiogenic Shock, but Patient Selection Key
Mandrola's Three Trials to Look For at the 2024 ACC
ACC 2024: Anticipating Advancements in Lipid Management
